Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Medicine.
Press releases published on July 24, 2025
Sight Sciences to Report Second Quarter 2025 Financial Results on August 7, 2025
GlobeNewswire
·
July 24, 2025
MENLO PARK, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and …
CervoMed to Present New Data from Phase 2b RewinD-LB Study at AAIC 2025 and Host Conference Call on July 28, 2025
GlobeNewswire
·
July 24, 2025
Company to share primary endpoint results at 32-Weeks from Extension phase following late-breaking presentations at Alzheimer's Association International Conference® (AAIC) 2025 Conference call and webcast to be held Monday, July 28 at 8:00 AM ET BOSTON, …
Treace to Report Second Quarter 2025 Financial Results on August 7, 2025
GlobeNewswire
·
July 24, 2025
PONTE VEDRA, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities …
RxSight, Inc. to Report Second Quarter 2025 Financial Results on August 7, 2025
GlobeNewswire
·
July 24, 2025
ALISO VIEJO, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, will report financial results for the …
OPKO Health to Report Second Quarter 2025 Financial Results on July 31
GlobeNewswire
·
July 24, 2025
MIAMI, July 24, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2025 after the close of the U.S. financial markets on Thursday, July 31, 2025. OPKO’s …
Teknova to Report Second Quarter 2025 Financial Results on August 7, 2025
GlobeNewswire
·
July 24, 2025
HOLLISTER, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, …
Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025
GlobeNewswire
·
July 24, 2025
LONDON, July 24, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, July 29, 2025 at 8:30 a.m. Eastern Time to report its second quarter 2025 …
Celcuity Announces First Patient Dosed in Phase 3 VIKTORIA-2 Clinical Trial of Gedatolisib as a First-Line Treatment for HR+/HER2- Advanced Breast Cancer
GlobeNewswire
·
July 24, 2025
MINNEAPOLIS, July 24, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that the first patient has been dosed in VIKTORIA-2, its Phase 3 …
Vaxart Submits Proxy Statement for Reverse Stock Split to Support Resumption of Trading on Nasdaq
GlobeNewswire
·
July 24, 2025
- Special Meeting of Stockholders to be Held Virtually on September 5, 2025 - - Live Stockholder Fireside Chat to be Scheduled to Answer Frequently Asked Stockholder Questions - - Nasdaq Hearings Panel Meeting Scheduled on August 14, 2025 - SOUTH SAN …
Cytokinetics to Announce Second Quarter Results On August 7, 2025
GlobeNewswire
·
July 24, 2025
SOUTH SAN FRANCISCO, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report second quarter results on August 7, 2025 at 4:00 PM Eastern Time. Following the announcement, …
Revolution Medicines Announces Publication of a Peer-Reviewed Research Paper in Science on the Discovery and Development of Zoldonrasib, a RAS(ON) G12D-Selective Inhibitor
GlobeNewswire
·
July 24, 2025
REDWOOD CITY, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced the publication of a peer- …
The Coaching Gap: Why Teens Need a Different Approach Than Adults
EIN Presswire
·
July 24, 2025
Coaching teens isn’t like coaching adults. It’s about trust, self-awareness …
Career in academia: Jörg Overmann transfers from Braunschweig to Munich to become scientific chair holder at LMU
EIN Presswire
·
July 24, 2025
Career in academia: Jörg Overmann transfers from Braunschweig to Munich to become scientific chair holder at LMU and full-time Director General BRAUNSCHWEIG/BRUNSWICK, LOWER SAXONY AREA, GERMANY, July 24, 2025 /EINPresswire.com/ -- Prof. Dr. Jörg …
Cellulose Gel Market estimated to garner $2.3 billion by 2031, with a CAGR of 4.5%
EIN Presswire
·
July 24, 2025
Increase in use of cellulose gel products in the food …
Imagine Dental Arts Reaches 40-Year Milestone in Lawrenceville, NJ
EIN Presswire
·
July 24, 2025
Imagine Dental Arts is changing lives with advanced dental implants, All-On-X restorations, full-mouth reconstructions, and sleep apnea care in Lawrenceville,NJ LAWRENCEVILLE, NJ, UNITED STATES, July 24, 2025 /EINPresswire.com/ -- Patients across …
LinkStep Announces the Launch of it's Reporting Software: Custom Forms with Powerful Analytics
EIN Presswire
·
July 24, 2025
LinkStep Launches Revolutionary Reporting Software: Custom Forms, Nested Questions, and Powerful Analytics for Data-Driven Insights. FORT WORTH, TX, UNITED STATES, July 24, 2025 /EINPresswire.com/ -- LinkStep, Inc., a trailblazing innovator in …
Drs. Nicolas & Asp Centers Expands Periodontics Department with the Appointment of Dr. Chantal Mehanna
EIN Presswire
·
July 24, 2025
Renowned Periodontist Joins Marina Walk Center, Bringing 15+ Years of Advanced Surgical and Cosmetic Expertise DUBAI, UNITED ARAB EMIRATES, July 24, 2025 /EINPresswire.com/ -- Drs. Nicolas …
Merakris Therapeutics Spotlights Investigational New Drug, MTX-001, with Innovation Showcase Win at 2025 Advanced Wound Care Summit
GlobeNewswire
·
July 24, 2025
RESEARCH TRIANGLE PARK, N.C., July 24, 2025 (GLOBE NEWSWIRE) -- Merakris Therapeutics announces it was selected as the winner of the 2025 Innovation Showcase at the Advanced Wound Care (AWC) Summit held last week in Boston. The award recognizes the most …
Cabometyx® approved in the EU for previously treated advanced neuroendocrine tumors
GlobeNewswire
·
July 24, 2025
Cabometyx® is the first and only systemic therapy to be approved in the European Union for previously treated unresectable or metastatic neuroendocrine tumors, regardless of tumor site, grade or previous non-somatostatin analogue-based systemic therapy1,2 …
Approbation de Cabometyx® dans l’UE pour les tumeurs neuroendocrines avancées précédemment traitées
GlobeNewswire
·
July 24, 2025
Cabometyx® est le premier et unique traitement systémique autorisé dans l’Union européenne pour les tumeurs neuroendocrines non résécables ou métastatiques précédemment traitées, indépendamment de la localisation de la tumeur, de sa gravité et de l’ …